SCHEMBL27847875

SCHEMBL27847875

N#Cc1ccn(-c2ccccc2F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ MGLL Q99685 1/20 0.43
▸ TUBB4A P04350 1/20 0.38
▸ TUBB P07437 1/20 0.38
▸ TUBA3C P0DPH7 1/20 0.38
▸ TUBA1B P68363 1/20 0.38
▸ TUBA4A P68366 1/20 0.38
▸ TUBB4B P68371 1/20 0.38
▸ TUBB3 Q13509 1/20 0.38
▸ TUBB2A Q13885 1/20 0.38
▸ TUBB8 Q3ZCM7 1/20 0.38
▸ TUBA3E Q6PEY2 1/20 0.38
▸ TUBA1A Q71U36 1/20 0.38
▸ TUBA1C Q9BQE3 1/20 0.38
▸ TUBB6 Q9BUF5 1/20 0.38
▸ TUBB2B Q9BVA1 1/20 0.38
▸ TUBB1 Q9H4B7 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4718646 0.79 IDO1 (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7076978 0.77 LMNA (0.44) ALDH1A1MAPTSTING1KDM4EHSD17B10
SCHEMBL8980842 0.75 ALDH1A1 (0.37) MGLLALDH1A1MAPTTSHRGRM5
SCHEMBL8772892 0.73 GRM5 (0.48) TSHRGRM5
SCHEMBL10509165 0.72 CYP1A2 (0.41) MGLLALDH1A1MAPTGRM5KDM4E
SCHEMBL27487817 0.72 PTGS1 (0.50) PTGS1PTGS2MGLLTUBB4ATUBB
SCHEMBL28226645 0.70 KDM4E (0.50) MGLLTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5859161 0.69 GAA (0.52) PTGS1PTGS2MGLLALDH1A1MAPT
SCHEMBL29946847 0.69 GAA (0.52) PTGS1PTGS2MGLLALDH1A1MAPT
SCHEMBL30239650 0.69 GRM4 (0.45) MGLLGRM5USP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113549054-B Vonoprazan fumarate intermediate and preparation method thereof 鲁南制药集团股份有限公司 2024-03-15 — — CN claimed
CN-117247344-A Preparation method of voronoi intermediate 5- (2-fluorophenyl) -1H-pyrrole-3-carbonitrile 安徽迪合永欣药业有限公司 2023-12-19 — — CN claimed
WO-2025098443-A1 METHOD FOR PREPARING 1-[5-(2-FLUOROPHENYL)-1-{[3-(3-METHOXYPROPOXY)PHENYL]SULFONYL}-1H-PYRROL-3-YL]-N-METHYLMETHYLAMINE AND HYDROCHLORIDE THEREOF 江苏柯菲平医药股份有限公司 2025-05-15 — — WO disclosed
CN-118344276-A Preparation method of voronoi fumarate intermediate 北京艾湃克斯医药研发有限公司 2024-07-16 — — CN disclosed
CN-113511995-B Preparation method of 5- (2-fluorophenyl) -1H-pyrrole-3-formaldehyde 四川科伦药物研究院有限公司 2024-07-09 — — CN disclosed
CN-117924141-A Preparation method of voronoi fumarate key impurities A and B 北京北陆益康医药研发有限公司 2024-04-26 — — CN disclosed
CN-113549054-B Vonoprazan fumarate intermediate and preparation method thereof 鲁南制药集团股份有限公司 2024-03-15 — — CN disclosed
CN-117126093-B Preparation method of voronoi intermediate 潍坊医学院 2023-12-29 — — CN disclosed
CN-117247344-A Preparation method of voronoi intermediate 5- (2-fluorophenyl) -1H-pyrrole-3-carbonitrile 安徽迪合永欣药业有限公司 2023-12-19 — — CN disclosed
CN-117247344-A Preparation method of voronoi intermediate 5- (2-fluorophenyl) -1H-pyrrole-3-carbonitrile 安徽迪合永欣药业有限公司 2023-12-19 — — CN disclosed
CN-117247344-A Preparation method of voronoi intermediate 5- (2-fluorophenyl) -1H-pyrrole-3-carbonitrile 安徽迪合永欣药业有限公司 2023-12-19 — — CN disclosed
CN-117126093-A Preparation method of voronoi intermediate 潍坊医学院 2023-11-28 — — CN disclosed
CN-116621813-A Preparation and purification method of voronoi fumarate 合肥信风科技开发有限公司 2023-08-22 — — CN disclosed
CN-113549054-A Vonoprazan fumarate intermediate and preparation method thereof 鲁南制药集团股份有限公司 2021-10-26 — — CN disclosed
CN-110028436-B Preparation method of Vonoprazan key intermediate 杭州中美华东制药有限公司 2020-10-16 — — CN disclosed
CN-108203450-A Preparation method and application of amino phosphonate containing arylpyrazole compound 南京工业大学 2018-06-26 — — CN disclosed
CN-102421753-A Process for preparing azole compounds TAKEDA PHARMACEUTICAL 2012-04-18 — — CN disclosed
Send feedback